Literature DB >> 8271030

Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake.

R Kubota1, K Kubota, S Yamada, M Tada, T Ido, N Tamahashi.   

Abstract

UNLABELLED: A substantial amount of macrophage infiltration occurs in both human and animal tumors. We previously showed that 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) uptake was higher in tumor-associated macrophages and young granulation tissues than in tumor cells. Differentiation of intratumoral non-neoplastic cells from neoplastic cells is important not only for the reduction of false-positives in FDG-PET tumor studies but also for patient management.
METHODS: A time-course study was performed using micro- and macro-autoradiography and tissue distribution in C3H/He mice bearing transplanted syngeneic FM3A mammary carcinoma and MH134 hepatoma was evaluated to analyze the intratumoral cellular dynamics of [18F]FDG and 2-deoxy-D-[3H]glucose in vivo.
RESULTS: The volume-doubling time in vivo was 1.3 days for MH134 and 4.9 days for FM3A, and the survival time of the host was 32.1 and 40.3 days, respectively. The peak uptake of both tracers in the tumor was 60 min after intravenous injection. The uptake by MH134 was 1.7-2.1 times higher than that by FM3A. The intracellular concentration as determined by counting the silver grains on micro-autoradiographic sections showed that the uptake by macrophages and focal small necrotic areas in both tumors was faster than the blood clearance until 15 min after tracer injection.
CONCLUSION: Thus, non-neoplastic cellular elements can be differentiated from viable neoplastic cells by means of the dynamic analysis of [18F]FDG uptake.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8271030

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  48 in total

Review 1.  Imaging of coronary inflammation with FDG-PET: feasibility and clinical hurdles.

Authors:  Ian S Rogers; Ahmed Tawakol
Journal:  Curr Cardiol Rep       Date:  2011-04       Impact factor: 2.931

2.  The role of 18F-FDG PET in characterising disease activity in Takayasu arteritis.

Authors:  Myles Webb; Anthony Chambers; Adil AL-Nahhas; Justin C Mason; Lucy Maudlin; Lucy Rahman; John Frank
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-01-17       Impact factor: 9.236

Review 3.  Targeting the vulnerable plaque: the evolving role of nuclear imaging.

Authors:  John R Davies; James F Rudd; Tim D Fryer; Peter L Weissberg
Journal:  J Nucl Cardiol       Date:  2005 Mar-Apr       Impact factor: 5.952

Review 4.  Imaging spectrum and pitfalls of ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with tuberculosis.

Authors:  Kimiteru Ito; Miyako Morooka; Ryogo Minamimoto; Yoko Miyata; Momoko Okasaki; Kazuo Kubota
Journal:  Jpn J Radiol       Date:  2013-05-30       Impact factor: 2.374

Review 5.  Molecular imaging of pulmonary disease in vivo.

Authors:  Robin S Dothager; David Piwnica-Worms
Journal:  Proc Am Thorac Soc       Date:  2009-08-15

6.  Noninvasive Positron Emission Tomography Imaging of Coronary Arterial Inflammation.

Authors:  Amr Abdelbaky; Ahmed Tawakol
Journal:  Curr Cardiovasc Imaging Rep       Date:  2011-02-01

7.  Importance of extracardiac FDG uptake to diagnose cardiac sarcoidosis.

Authors:  Nobuhiro Tahara; Munehisa Bekki; Yoichi Sugiyama; Atsuko Tahara; Yoshihiro Fukumoto
Journal:  J Nucl Cardiol       Date:  2018-09-05       Impact factor: 5.952

8.  Clinical relevance of imaging proliferative activity in lung nodules.

Authors:  Andreas K Buck; Martin Hetzel; Holger Schirrmeister; Gisela Halter; Peter Möller; Clemens Kratochwil; Andreas Wahl; Gerhard Glatting; Felix M Mottaghy; Torsten Mattfeldt; Bernd Neumaier; Sven N Reske
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-12-14       Impact factor: 9.236

9.  Usefulness of additional delayed regional F-18 Fluorodeoxy-Glucose Positron Emission Tomography in the lymph node staging of Non-Small Cell Lung Cancer patients.

Authors:  Young So; June-Key Chung; Jae Min Jeong; Dong Soo Lee; Myung Chul Lee
Journal:  Cancer Res Treat       Date:  2005-04-30       Impact factor: 4.679

10.  18F-FDG PET for the lymph node staging of non-small cell lung cancer in a tuberculosis-endemic country: is dual time point imaging worth the effort?

Authors:  Ruoh-Fang Yen; Ke-Cheng Chen; Jang-Ming Lee; Yeun-Chung Chang; Jane Wang; Mei-Fang Cheng; Yen-Wen Wu; Yung-Chie Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-02-19       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.